Insulet Operating Income 2010-2024 | PODD
Insulet annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Insulet operating income for the quarter ending March 31, 2024 was $0.057B, a 105.42% increase year-over-year.
- Insulet operating income for the twelve months ending March 31, 2024 was $0.249B, a 809.49% increase year-over-year.
- Insulet annual operating income for 2023 was $0.22B, a 485.11% increase from 2022.
- Insulet annual operating income for 2022 was $0.038B, a 70.16% decline from 2021.
- Insulet annual operating income for 2021 was $0.126B, a 144.66% increase from 2020.
| Insulet Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $220 |
| 2022 | $38 |
| 2021 | $126 |
| 2020 | $52 |
| 2019 | $50 |
| 2018 | $27 |
| 2017 | $-7 |
| 2016 | $-11 |
| 2015 | $-49 |
| 2014 | $-9 |
| 2013 | $-29 |
| 2012 | $-36 |
| 2011 | $-42 |
| 2010 | $-39 |
| 2009 | $-59 |
| Insulet Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-03-31 | $57 |
| 2023-12-31 | $106 |
| 2023-09-30 | $55 |
| 2023-06-30 | $31 |
| 2023-03-31 | $28 |
| 2022-12-31 | $24 |
| 2022-09-30 | $3 |
| 2022-06-30 | $-27 |
| 2022-03-31 | $38 |
| 2021-12-31 | $50 |
| 2021-09-30 | $34 |
| 2021-06-30 | $26 |
| 2021-03-31 | $16 |
| 2020-12-31 | $-7 |
| 2020-09-30 | $24 |
| 2020-06-30 | $28 |
| 2020-03-31 | $8 |
| 2019-12-31 | $18 |
| 2019-09-30 | $17 |
| 2019-06-30 | $8 |
| 2019-03-31 | $7 |
| 2018-12-31 | $16 |
| 2018-09-30 | $7 |
| 2018-06-30 | $4 |
| 2018-03-31 | |
| 2017-12-31 | $-1 |
| 2017-09-30 | $2 |
| 2017-06-30 | $-3 |
| 2017-03-31 | $-5 |
| 2016-12-31 | $-4 |
| 2016-09-30 | $2 |
| 2016-06-30 | $-1 |
| 2016-03-31 | $-8 |
| 2015-12-31 | $-13 |
| 2015-09-30 | $-15 |
| 2015-06-30 | $-14 |
| 2015-03-31 | $-7 |
| 2014-12-31 | $1 |
| 2014-09-30 | $-3 |
| 2014-06-30 | $-5 |
| 2014-03-31 | $-2 |
| 2013-12-31 | $0 |
| 2013-09-30 | $-17 |
| 2013-06-30 | $-6 |
| 2013-03-31 | $-6 |
| 2012-12-31 | $-6 |
| 2012-09-30 | $-8 |
| 2012-06-30 | $-11 |
| 2012-03-31 | $-11 |
| 2011-12-31 | $-11 |
| 2011-09-30 | $-10 |
| 2011-06-30 | $-15 |
| 2011-03-31 | $-7 |
| 2010-12-31 | $-10 |
| 2010-09-30 | $-8 |
| 2010-06-30 | $-10 |
| 2010-03-31 | $-11 |
| 2009-12-31 | $-12 |
| 2009-09-30 | $-13 |
| 2009-06-30 | $-16 |
| 2009-03-31 | $-17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $14.134B | $1.697B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $180.765B | 23.67 |
| Stryker (SYK) | United States | $129.618B | 31.05 |
| Boston Scientific (BSX) | United States | $112.981B | 35.99 |
| Medtronic (MDT) | Ireland | $100.927B | 15.11 |
| EssilorLuxottica (ESLOY) | France | $99.128B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.585B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.716B | 27.53 |
| ResMed (RMD) | United States | $28.121B | 26.40 |
| Terumo (TRUMY) | Japan | $24.403B | 34.46 |
| Koninklijke Philips (PHG) | Netherlands | $22.841B | 18.13 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.328B | 14.26 |
| Baxter (BAX) | United States | $17.045B | 12.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.833B | 0.00 |
| Demant (WILYY) | Denmark | $9.370B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.790B | 25.48 |
| BellRing Brands (BRBR) | United States | $7.453B | 35.06 |
| Lantheus Holdings (LNTH) | United States | $5.565B | 13.87 |
| GN Store Nord (GNNDY) | Denmark | $4.222B | 23.71 |
| Haemonetics (HAE) | United States | $4.215B | 20.79 |
| Perrigo (PRGO) | Ireland | $3.501B | 10.61 |
| Prestige Consumer Healthcare (PBH) | United States | $3.437B | 16.35 |
| Neogen (NEOG) | United States | $3.386B | 32.56 |
| ICU Medical (ICUI) | United States | $2.893B | 25.54 |
| Envista Holdings (NVST) | United States | $2.858B | 11.79 |
| TG Therapeutics (TGTX) | United States | $2.749B | 77.35 |
| Green Thumb Industries (GTBIF) | United States | $2.552B | 49.96 |
| Agios Pharmaceuticals (AGIO) | United States | $2.448B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.225B | 12.35 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 54.13 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.804B | 0.00 |
| Warby Parker (WRBY) | United States | $1.592B | 0.00 |
| InMode (INMD) | Israel | $1.532B | 8.14 |
| AdaptHealth (AHCO) | United States | $1.332B | 9.90 |
| Verano Holdings (VRNOF) | United States | $1.246B | 0.00 |
| AtriCure (ATRC) | United States | $1.084B | 0.00 |
| Owens & Minor (OMI) | United States | $1.033B | 9.00 |
| National Vision Holdings (EYE) | United States | $1.028B | 32.72 |
| BioLife Solutions (BLFS) | United States | $0.987B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.679B | 14.46 |
| Evolus (EOLS) | United States | $0.679B | 0.00 |
| PetIQ (PETQ) | United States | $0.656B | 21.21 |
| VAREX IMAGING (VREX) | United States | $0.602B | 14.16 |
| Surmodics (SRDX) | United States | $0.599B | 37.54 |
| Quanterix (QTRX) | United States | $0.506B | 0.00 |
| ZimVie (ZIMV) | United States | $0.498B | 42.44 |
| Canopy Growth (CGC) | Canada | $0.491B | 0.00 |
| Valneva SE (VALN) | France | $0.488B | 0.00 |
| Biote (BTMD) | United States | $0.463B | 10.67 |
| Jin Medical (ZJYL) | China | $0.403B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.394B | 0.00 |
| Cerus (CERS) | United States | $0.325B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.315B | 10.14 |
| Zynex (ZYXI) | United States | $0.296B | 40.52 |
| MacroGenics (MGNX) | United States | $0.266B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 25.19 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.243B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 14.85 |
| Omeros (OMER) | United States | $0.235B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.233B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.153B | 21.76 |
| Capricor Therapeutics (CAPR) | United States | $0.153B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.137B | 0.00 |
| Veru (VERU) | United States | $0.123B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 10.26 |
| Brainsway (BWAY) | Israel | $0.101B | 0.00 |
| InterCure (INCR) | Israel | $0.092B | 15.46 |
| Cellectar Biosciences (CLRB) | United States | $0.090B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.073B | 4.75 |
| MariMed (MRMD) | United States | $0.069B | 0.00 |
| Safety Shot (SHOT) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.051B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.049B | 0.00 |
| Bright Green (BGXX) | United States | $0.048B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.041B | 14.90 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.021B | 0.00 |
| Agape ATP (ATPC) | $0.016B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |